Digital Billboard Campaigns Connect Families with Free Summer Meal Programs and Summer Learning Resources to Support Their Kids' Well-Being This Season As millions of children across America begin their summer break,Clear Channel Outdoor (CCO) is continuing its partnership with two leading national organizations, Share Our Strength's No Kid Hungry campaign and the National Summer Learning […]

Bloomberg announced today that ActinverAsset Management, one of Mexico's largest asset management firms with over 360 billion pesos in assets under management (AUM), has adopted Bloomberg's integrated buy-side solutions to implement a seamless order and risk management workflow. https://mma.prnewswire.com/media/649927/Bloomberg_Black_Logo.jpg “Actinver Asset Management is excited about our implementation of Bloomberg's solutions to position us for even

Commvault (NASDAQ: CVLT) – Commvault will webcast a discussion of its first quarter fiscal year 2026 earnings results on Tuesday, July 29, 2025 beginning at 8:30 a.m. EST athttp://ir.commvault.com. https://mma.prnewswire.com/media/460887/commvault_new__logo.jpg Investors can access the live webcast by visiting http://ir.commvault.com. Investors may also access the call by dialing Toll Free: (888) 596-4144 or International: (646) 698-2525

eToro Secures $250 Million Revolving Credit Facility GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, today announced the closing of a new three year $250 million senior unsecured revolving credit facility (“the Facility”). The Facility provides eToro

Conference Call Scheduled for Thursday, July 31, 2025 at 9:00am ET – Silicom Ltd. (NASDAQ: SILC), an industry-leading provider of high-performance server/appliances networking solutions,announced today that it will be releasing its second quarter 2025 results on Thursday, July 31, 2025. https://mma.prnewswire.com/media/733229/3093540/Silicom_Ltd_Logo.jpg The Company will be hosting a conference call on that same day at 9:00am

Veteran Global Clinical Leader, Honored for Helping Develop One of the First COVID Vaccines, to Support Rollout of PhaseV's New AI Platform for Clinical Development PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr. Ivarsson most

INReport e-Invoice Empowers Malaysian Companies to Seamlessly Comply with New Nationwide Tax Mandate KUALA LUMPUR, MY / ACCESS Newswire / July 1, 2025 / AsiaFIN Holdings Corp. (OTCQB:ASFH), a leading fintech financial ecosystem enabler, today announced that its centralized regulatory technology (RegTech) solution, INReport e-Invoice, has surpassed 100 customers across Asia. INReport e-Invoice is a

Powered by Causal AI and Real-Time Patient-Level Data and Analytics, the ClinOps Platform Enables Faster and Smarter Decision Making Across Trial Lifecycles PhaseV, a leader in AI/ML-driven clinical development, today announced the launch of the ClinOps platform, a next-generation solution designed to modernize clinical trial operations through precision-guided site selection and dynamic performance monitoring. Built

Organizations face new digital accessibility requirements and rising penalties for non-compliance AudioEye, Inc. (Nasdaq: AEYE) (“AudioEye” or the “Company”), the industry-leading digital accessibility company, has expanded its presence in the European Union to support growing demand as enforcement of the European Accessibility Act (“EAA”) begins. Now in effect, the EAA introduces wide-reaching requirements for businesses

Two oral presentations to highlight the safety, immunogenicity, and future development of AV-1959R for primary and secondary prevention of Alzheimer's disease Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations-the Phase 1 clinical results and the Phase 2 secondary prevention study design for its licensed lead